Scarica l'app Stockscreener
56.25
0.76%
-0.43
Pre-mercato:
56.04
-0.21
-0.37%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRSP Giù?
Forum
Previsione
Crispr Therapeutics Ag Borsa (CRSP) Ultime notizie
12 Days of Investing: My Top 12 Stocks to Buy Before 2026 - The Motley Fool
Marex Group plc Invests $948,000 in CRISPR Therapeutics AG $CRSP - MarketBeat
Biomedical Crispr Gene Editing Market Set for Dynamic - openPR.com
Nikko Asset Management Americas Inc. Sells 125,618 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
2 Healthcare Stocks to Buy Ahead of the New Year - Finviz
CRISPR Therapeutics Stock (CRSP) in December 2025: Price, Forecast, CASGEVY Growth and Takeover Rumors - ts2.tech
New York State Common Retirement Fund Increases Position in CRISPR Therapeutics AG $CRSP - MarketBeat
Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report? - sharewise.com
Buy Rating for Crispr Therapeutics AG: Pediatric Market Potential and Long-term Growth Opportunities - TipRanks
Is CRISPR Therapeutics (CRSP) Turning Early CTX310 Signals Into a Durable Genetic Medicine Platform? - Sahm
Guggenheim Capital LLC Sells 37,778 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
Norges Bank Invests $19.77 Million in CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics AG Stock Analysis and ForecastMarket Sentiment Indicators & High Profit Market Ideas - earlytimes.in
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know - MSN
CRISPR Therapeutics stock rating reiterated at Market Outperform by Citizens - Investing.com Nigeria
(CRSP) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
CRISPR Therapeutics (CRSP): Reassessing Valuation After Casgevy Approvals and Growing 2025 Revenue Expectations - Sahm
Jump Financial LLC Buys New Shares in CRISPR Therapeutics AG $CRSP - MarketBeat
2 Stocks That Could Soar by 52% and 282%, According to Wall Street - Finviz
CRISPR Therapeutics (CRSP) Stock on 7 December 2025: Latest Price, News, Forecasts and Gene‑Editing Outlook - ts2.tech
State Board of Administration of Florida Retirement System Acquires New Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics AG: Stock surge amid challenges - MSN
Crispr Therapeutics AG: Stock Surge Amid Challenges - TipRanks
Vertex's gene therapy shows promise in younger children with blood disorders - Reuters
50,250 Shares in CRISPR Therapeutics AG $CRSP Purchased by Philadelphia Trust Co. - MarketBeat
Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown - MSN
Will CRISPR Therapeutics AG (1CG) stock return to pre crash levelsWeekly Trade Report & Weekly High Potential Stock Alerts - Newser
Is CRISPR Therapeutics AG stock a bargain at current levelsJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Cathie Wood’s Buys And Rumors Aside, Here’s Why Crispr Therapeutics Is A Strong Buy (CRSP) - Seeking Alpha
CRISPR Therapeutics AG $CRSP Shares Bought by Legal & General Group Plc - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Nasdaq Index Biotech Momentum - Kalkine Media
Bernstein Reaffirms Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail
Will CRISPR Therapeutics AG stock continue upward momentumLayoff News & Weekly Top Stock Performers List - Newser
Can CRISPR Therapeutics AG (1CG) stock deliver double digit returnsMarket Volume Summary & Long Hold Capital Preservation Tips - Newser
How dovish Fed policy supports CRISPR Therapeutics AG (1CG) stockJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - Newser
Will CRISPR Therapeutics AG (1CG) stock outperform benchmarksMarket Sentiment Summary & High Conviction Buy Zone Picks - Newser
Will CRISPR Therapeutics AG (1CG) stock outperform value peers2025 Price Targets & High Accuracy Trade Alerts - Newser
Will CRISPR Therapeutics AG (1CG) stock hit analyst forecastsMarket Sentiment Summary & AI Based Trade Execution Alerts - Newser
Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance - MSN
CRISPR Therapeutics: CTX310 De-Risks, CASGEVY Disappoints Amid Takeover Rumors (CRSP) - Seeking Alpha
The Best CRISPR Companies for 2025 - The Motley Fool
Crispr Therapeutics (CRSP) Gains Amid Takeover Speculation - GuruFocus
Crispr Therapeutics pares loss amid takeover speculation (CRSP:NASDAQ) - Seeking Alpha
Inflation Data: Can SGBX stock maintain operating marginsMarket Performance Recap & Detailed Earnings Play Alerts - BỘ NỘI VỤ
Crispr Therapeutics (CRSP) Shares React to M&A Rumor - GuruFocus
Crispr Therapeutics rumor highlighted in Betaville blog - TipRanks
Loomis Sayles & Co. L P Has $41.68 Million Stock Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat
What CRISPR Therapeutics’ (CRSP) Latest Trial Results Mean for Investors - MSN
West Family Investments Inc. Takes Position in CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics AG $CRSP Shares Sold by Cetera Investment Advisers - MarketBeat
Ameritas Investment Partners Inc. Purchases Shares of 8,451 CRISPR Therapeutics AG $CRSP - MarketBeat
Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy - Insider Monkey
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):